On ECHEMI
Home > Drugs > Zhaoke Pharmaceutical (Hefei) Co., Ltd.
Zhaoke Pharmaceutical (Hefei) Co., Ltd.
  • Founded in:

    1994-02-07
  • Country:

    China China
  • Address:

    Hefei High-tech Industrial Development Zone, Anhui Province
  • Tax NO.:

    91340100610308045Q
  • Registered Funds:

    $2 million
  • Email:

Related Drugs
Low Molecular Weight Heparin Calcium for Injection
Name Description Content CAS NO. Registered Holders
ENOXAPARIN, [1-3H]

Anticoagulants are used to prevent and treat thrombotic diseases (such as deep vein thrombosis), prevent clotting during hemodialysis; treat acute coronary artery disease (such as unstable angina and myocardial infarction); are used in patients with ischemic stroke who have a hypercoagulable state; reduce tumor metastasis and inhibit angiogenesis to slow tumor growth; and prevent inflammation in autoimmune diseases by inhibiting heparinase.

More

Anticoagulants are used to prevent and treat thrombotic diseases (such as deep vein thrombosis), prevent clotting during hemodialysis; treat acute coronary artery disease (such as unstable angina and myocardial infarction); are used in patients with ischemic stroke who have a hypercoagulable state; reduce tumor metastasis and inhibit angiogenesis to slow tumor growth; and prevent inflammation in autoimmune diseases by inhibiting heparinase.

0
Low Molecular Weight Heparin Calcium for Injection
Name Description Content CAS NO. Registered Holders
ENOXAPARIN, [1-3H]

Anticoagulants are used to prevent and treat thrombotic diseases (such as deep vein thrombosis), prevent coagulation during hemodialysis; treat acute coronary heart disease (especially unstable angina and myocardial infarction); are used in patients with ischemic stroke in hypercoagulable conditions; reduce tumor metastasis and inhibit angiogenesis to slow tumor growth; and prevent inflammation in autoimmune diseases by inhibiting heparinase.

More

Anticoagulants are used to prevent and treat thrombotic diseases (such as deep vein thrombosis), prevent coagulation during hemodialysis; treat acute coronary heart disease (especially unstable angina and myocardial infarction); are used in patients with ischemic stroke in hypercoagulable conditions; reduce tumor metastasis and inhibit angiogenesis to slow tumor growth; and prevent inflammation in autoimmune diseases by inhibiting heparinase.

0
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.